Amgen Names Michael Severino, M.D., Senior Vice President, Global Development and Corporate Chief Medical Officer

Newsflash:

Trial Supports Earlier Use of a Prostate Cancer Drug
Roche Alzheimer's Drug Picked for Major Test
Plavix Patent Loss Doesn’t Mean Gain by Competing Blood Thinners
Pediatric Tumors Respond to Xalkori
Hospira Recalls Pain Drug Cartridges on Over-Fill Concerns
Home HIV Test Advances

Amgen Names Michael Severino, M.D., Senior Vice President, Global Development and Corporate Chief Medical Officer

Amgen Press Release (02/14/12)
Amgen has announced that Michael Severino has been named senior vice president, Global Development and Corporate Chief Medical Officer, effective immediately. Severino, formerly vice president, Global Development at Amgen, will replace Sean Harper, who was appointed Amgen's executive vice president, Research and Development.

Read the complete article

Share |

Sponsor Highlights

NCPA's Medication Adherence Cand Prescription Drug Revenue Calculator